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ABSTRACT 
Major depression and coronary heart disease are two strongly linked, major causes of 
death and disability. After an acute coronary event, many patients are referred to cardiac 
rehabilitation (CR), a medically supervised exercise intervention and lifestyle training 
program. Depression may partially account for poor CR adherence and resulting 
cardiovascular problems in patients with a history of heart disease; however, underlying 
mechanisms through which depression impacts cardiac functioning are not well 
understood. The current project tests a theoretical model in which CR adherence (i.e., 
number of CR sessions attended) mediates the relation between baseline depression and 
cardiorespiratory fitness after CR. A community sample of 858 older adults initiating CR 
after hospitalization for a coronary event completed a symptom-limited exercise stress 
test before and after the 12-week program. Cardiorespiratory fitness was measured via 
VO2max, peak MET, and total duration of the stress test. Depression was measured at 
baseline using the Patient Health Questionnaire Depression Scale. CR adherence did not 
mediate the relation between baseline depression scores and fitness outcomes. Path 
analyses revealed that higher baseline depression severity predicted lower likelihood of 
CR completion (i.e., completion of all 36 sessions, or fewer if limited by insurance or 
terminated early for good prognosis) in the full sample. Higher levels of depression 
predicted poorer CR adherence in a subsample of 74 patients with moderate to severe 
depression. These findings lend support to depression as a predictor of treatment 
nonadherence in CR. Screening for depression in the context of coronary heart disease 
and implementing evidence-based depression interventions in secondary prevention 
settings can help alleviate a massive public health burden. 
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CHAPTER 1: INTRODUCTION 
Public Health Significance 
Depression and heart disease are two of the leading causes of disability worldwide 
(CDC, 2016) and among the top five chronic conditions encountered in the care of older 
adults (Whooley, 2006), a growing demographic worldwide. Major depressive disorder is 
a debilitating mental health problem estimated to cost more than $210 billion per year in 
the United States (Greenberg et al., 2015). Depression is also strongly linked to heart 
disease, the leading cause of death among adult men and women in the United States 
(CDC, 2016). According to American Heart Association (AHA) statistics, although 
mortality rates have declined in recent decades, an estimated 785,000 Americans have 
heart attacks each year and approximately 475,000 Americans will have a recurrent 
attack each year (Roger et al., 2011). It is estimated that approximately half of all middle-
aged men and one-third of middle-aged women in the United States will develop some 
manifestation of coronary heart disease during their lifetime (Lloyd-Jones et al., 1999). 
Thus, clinical interventions and prevention efforts focused on depression and heart 
disease bear a tremendous impact on global public health. 
Background on Coronary Heart Disease (CHD) 
Medical Terminology. Coronary heart disease (CHD) is a broad term that refers 
to cardiac disease caused by atherosclerosis (i.e., the hardening and narrowing of arteries) 
or myocardial ischemia (i.e., restricted oxygenated blood flow to the heart). The 
narrowing of small blood vessels that supply blood to the heart can weaken the heart 
muscle over time. Temporary shortages in oxygen to the heart typically result in angina 
or chest pain. A myocardial infarction (MI), colloquially known as a heart attack, occurs 
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when the heart suffers severe or prolonged deprivation of oxygen-rich blood. Congestive 
heart failure is a more severe, chronic condition that occurs when the heart becomes 
permanently enlarged, the left ventricular ejection fraction or pumping capacity is 
reduced, and the individual becomes short of breath with little physical exertion.  
Medical procedures and treatments for acute coronary events may include surgical 
intervention. Percutaneous coronary interventions (PCI; e.g., balloon angioplasty, 
coronary stent placement) are minimally invasive procedures in which a stent is placed to 
open up coronary arteries, allowing blood to circulate unobstructed to the heart muscle. 
Coronary artery bypass graft (CABG) is a more complicated type of surgery during 
which arteries or veins from another area of the body are surgically grafted to bypass the 
narrowed coronary arteries. Medications (e.g., lipid-lowering drugs, antiplatelet agents, 
anticoagulants) may also be prescribed for secondary preventative measures.  
Traditional Risk Factors for CHD. A number of medical conditions and health 
behaviors are well established as risk factors for heart disease that increase morbidity and 
mortality. These risk factors include but are not limited to nicotine use, hypertension, 
hypercholesterolemia, diabetes mellitus, obesity, and physical inactivity. The relative risk 
of cardiac mortality associated with each pack of cigarettes smoked per day is 
approximately 1.39 (Multiple Risk Factor Intervention Trial Research Group, 1986). A 
prolonged increase in blood pressure of 10 mm Hg above normal diastolic pressure is 
associated with a 37% increased risk of cardiovascular disease (Wilson et al., 1998). 
Cardiac mortality increases 9% for each 10 mg/dL increase in plasma cholesterol 
(Anderson et al., 1987), such that individuals in the highest quartile of plasma cholesterol 
levels are three times more likely to die of cardiovascular disease than those in the lowest 
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quartile (Multiple Risk Factor Intervention Trial Research Group, 1986). Diabetes is also 
associated with a three- to four-fold increased risk of cardiovascular disease and mortality 
(Garcia et al., 1974). The relative risk of cardiovascular disease in overweight (BMI 25.0 
to 29.9) and obese (BMI ≥ 30) individuals, compared with individuals of normal weight 
(BMI 18.5 to 24.9) is approximately 1.2 and 1.64, respectively (Wilson et al., 2002).  
The aforementioned risk factors for heart disease are largely modifiable and 
treatable (Center for Disease Control and Prevention, 2015). Chronic medical conditions 
such as obesity, hyperlipidemia, hypertension, and insulin resistance/diabetes mellitus 
can be improved through health behaviors. Hence, lifestyle changes (e.g., heart-healthy 
dieting, weight management, physical activity, managing stress, quitting smoking, 
limiting alcohol intake, medication adherence) are emphasized in clinical interventions 
for CHD as well as in health promotion and disease prevention.  
Epidemiology of Depression in CHD 
Major depressive disorder (MDD) is characterized by clinical impairment and 
distress associated with five or more symptoms (e.g., depressed mood, anhedonia, change 
in appetite/weight, disrupted sleep, fatigue, psychomotor retardation or agitation, feelings 
of worthlessness or inappropriate guilt, poor concentration, suicidal ideation) that have 
persisted for at least two weeks. CHD patients may differ from depressed but otherwise 
healthy patients in ways that have important implications for assessment and treatment 
(Kronish, Krupka, & Davidson, 2012; Lett et al., 2005). First, cardiac patients tend to be 
older individuals and present with medical comorbidities, which can make it challenging 
to tease apart depression from symptoms of organic disease. Typical symptoms of 
depression, like sadness, guilt, or suicidal ideation, are often replaced by feelings of 
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anger, irritability, anxiety, and/or stress (Lespérance & Frasure-Smith, 2000). Cardiac 
patients are more likely to endorse somatic symptoms (e.g., fatigue, disturbed sleep, 
changes in appetite, dyspnea, palpitations) and attribute them to medical conditions than 
to emotional distress (Kop, 2012). In fact, somatic symptoms are often associated with 
more severe levels of depression in cardiac patients (Carney & Freedland, 2012). Second, 
CHD patients may be less willing to participate in emotionally challenging or time-
consuming treatments on top of the burden of coping with chronic disease and acute 
health events or procedures (Lett et al., 2005). Third, depressive symptoms that emerge in 
reaction to a stressful medical event (e.g., adjustment disorder subsequent to an acute 
coronary event) may spontaneously remit without treatment (Kronish et al., 2012). 
Clinical depression is often comorbid with chronic medical conditions, including 
heart disease, diabetes, and hypertension. It is also associated with genetic and behavioral 
risk factors of CHD, namely noncompliance with medical treatments, sedentary lifestyle, 
obesity, and smoking (Carney & Freedland, 2008; Lett et al., 2004). The estimated point 
prevalence of MDD in patients following MI is approximately 20% (Lichtman et al., 
2008; Thombs et al., 2005), that is, three times the prevalence of current depression in the 
general adult population (6.6%, Kessler et al., 2003). Some cross-sectional studies report 
even higher depression prevalence rates in coronary artery disease and MI patients (up to 
47%; Lett et al., 2004; van Melle et al., 2004) and in heart failure patients (up to 54%; 
Rutledge et al., 2006). The highest depression prevalence rates most often characterize 
patients with congestive heart failure (Jiang et al., 2001; Rutledge et al., 2006; Whooley 
et al., 2006) and unstable angina (Lett et al., 2004), as well as patients awaiting CABG 
(Lett et al., 2004). It should be noted that heterogeneity in prevalence rates might be 
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partially accounted for by varied methodological approaches, with higher rates of 
depression in studies using self-report measures and lower rates reported in studies that 
relied on diagnostic interviews (Rutledge et al., 2006).  
Depression as a Risk Factor for Adverse Outcomes in Healthy Patients  
There is an accumulating body of research that not only links depression to 
adverse outcomes but also supports depression as a consistent predictor of first onset of 
coronary artery disease and myocardial infarctions (Kessler, 2012; Pratt et al., 1996, 
Scherrer et al., 2009, Van der Kooy, et al., 2007; Wulsin & Singal, 2003). In order to 
shed light on the issue of directionality and to definitively conclude whether depression is 
a significant risk factor for the development of heart disease, researchers have conducted 
numerous prospective studies in healthy patients without a history of heart disease. In a 
community-based longitudinal study, 450 subjects with a cardiac disease diagnosis and 
2,397 subjects without cardiac disease were followed for 4 years and evaluated for major 
depression using the Center for Epidemiologic Studies – Depression (CES-D; Penninx et 
al., 2001). The relative risk of cardiac mortality due to cardiac disease was 3.0 for cardiac 
patients with major depression compared with nondepressed cardiac patients. Similarly, 
among patients without cardiac disease, those with MDD were 3.9 times more likely to 
die of cardiac causes compared with those without depression at baseline, even after 
controlling for potentially confounding factors such as age, sex, level of education, BMI, 
smoking status, alcohol intake, blood pressure, and comorbid medical conditions (e.g., 
stroke, diabetes mellitus, lung disease, cancer). According to a meta-analysis of 11 
prospective cohort studies examining depression as a predictor for CHD in healthy 
subjects with depression, both MDD and depressive symptoms showed a statistically 
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significant overall effect size (Rugulies, 2002). A sensitivity analysis revealed that MDD 
(RR = 2.69, 95% CI 1.63–4.43, p < 0.001) was a stronger, more consistent predictor of 
CHD than depressive mood (RR = 1.49, 95% CI 1.16–1.92, p = 0.02). Another meta-
analysis of 30 prospective studies examined the relation between depression and the risk 
of CHD and MI in participants with no history of CHD over a follow-up duration ranging 
from 2 to 37 years (Gan et al., 2014). Pooled relative risks were 1.30 (95% CI, 1.22-1.40) 
for CHD and 1.30 (95% CI, 1.18-1.44) for MI, suggesting that depression is 
independently and significantly associated with an increased risk of CHD and MI.  
Depression as a Risk Factor for Poorer Outcomes in Patients with Heart Disease  
Epidemiological studies examining the link between depression and CHD have 
found that major depression and elevated depressive symptoms are associated with worse 
prognosis (i.e., earlier and more severe cardiac events) in patients with a history of CHD 
(Lichtman et al., 2008). In a meta-analysis of depression in heart failure patients, 
aggregated results across a range of clinical outcomes indicated that more severe 
depression was associated with a substantially worse prognosis, after adjusting for 
multiple covariates such as age and ejection fraction (Rutledge et al., 2006). This dose-
response relationship between depressive symptoms and adverse CHD outcomes is 
stronger for major depression than for minor depression (Goldston & Baillie, 2008).  
There is general consensus that depression is an independent risk factor for heart 
disease, as it is specifically linked with higher risk for second cardiovascular events, 
premature death, and cardiac mortality in patients with established heart disease 
(Lichtman et al., 2008; Whooley et al., 2008). A meta-analysis of 22 prospective studies 
comparing the cardiovascular prognosis of depressed MI patients to a non-depressed MI 
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control group examined the association of depression with mortality and cardiovascular 
events within 2 years of the index MI (van Melle et al., 2004). Post-MI depression was 
significantly associated with all-cause mortality (OR fixed = 2.38), cardiac mortality (OR 
fixed = 2.59) and new cardiovascular events (e.g., recurrent MI; OR random = 1.95). 
Parashar and colleagues (2006) prospectively followed a sample of 1,873 depressed 
patients with acute MI and classified patients as having transient (only at baseline), new 
(only at 1 month), or persistent (at both baseline and 1 month) depression. Depression 
was assessed with the 9-item Primary Care Evaluation of Mental Disorders Brief Patient 
Health Questionnaire (PHQ-9), using a standard cutoff of 10 to indicate at least moderate 
levels of major depression. Higher depression severity during hospitalization for MI 
predicted more severe depression at 1-month post-discharge, such that higher levels of 
depression at baseline predicted higher levels of depression at 1-month. In comparison to 
non-depressed patients, all three “persistence” categories of depressed patients, 
irrespective of depression onset at baseline or in the first month after hospitalization, 
demonstrated worse outcomes as defined by more rehospitalizations, higher mortality 
rates, more frequent angina, greater physical limitations, and poorer quality of life at 6 
months after discharge. 
Similar findings have been reported in multiple patient cohorts with varying 
forms of heart disease. The Heart and Soul Study (Whooley et al., 2008) followed 1,017 
outpatients with stable CHD over a mean of 4.8 (SD = 1.8) years and found that baseline 
depressive symptoms measured by the PHQ-9 were associated with a 31% higher rate of 
adverse cardiovascular events (e.g., heart failure, MI, stroke, transient ischemic attack, 
death). Connerney and colleagues (2001) followed 309 CABG patients over 1 year and 
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found that patients who met modified DSM-IV criteria for MDD in the few days after 
surgery were more than twice as likely as non-depressed patients to have a cardiac event 
within 12 months after surgery. In a longitudinal study of 817 CABG patients, depression 
was assessed at baseline and at 6 months post-surgery (Blumenthal et al., 2003). 
Moderate to severe levels of depression, measured by the CES-D, that persisted 6 months 
after surgery, were independently associated with a 2- to 3-fold increase in risk for 
mortality. Another study (Jiang et al., 2001) prospectively followed 374 patients 
hospitalized with congestive heart failure and found that major depression was associated 
with increased mortality at 3 months (OR = 2.5) and 1 year (OR = 2.23) as well as 
rehospitalization at 3 months (OR = 1.90) and 1 year (OR = 3.07).  
Depression: An Independent Risk Factor for CHD  
Traditional cardiac risk factors do not adequately account for the effect of 
depression on CHD outcomes (Carney & Freedland, 2008). There are obvious 
methodological differences across studies, including sample size, sample characteristics, 
selection of covariates, definitions of depression and adverse cardiac outcomes, and 
length of follow up. However, as a whole, the epidemiological literature provides robust 
and compelling evidence for a strong, consistent dose-response relationship between 
depression and prognosis after adjusting for potential confounders (Frasure-Smith & 
Lespérance, 2005; Goldston & Baillie, 2008; Lichtman et al., 2008). Although it remains 
to be confirmed whether depression is a causal risk for heart disease, the evidence 
overwhelmingly supports the assertion that depression is an independent risk factor for 
CHD in healthy patients as well as a predictor for worse outcomes in individuals with 
established heart disease, after adjusting for severity of CHD as well as other medical and 
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demographic factors (Carney & Freedland, 2008). In fact, given the preponderance of 
evidence linking depression and adverse cardiac outcomes, the AHA issued a scientific 
statement urging national health organizations to elevate depression to the status of a risk 
factor for adverse medical outcomes in patients with acute coronary syndrome (Lichtman 
et al., 2014). This recommendation places depression on par with moderate risk factors 
such as hypertension, hypercholesterolemia, and obesity (Kronish et al., 2006). Given the 
public health significance of depression and CHD and the comorbidity of these chronic 
conditions, depression is arguably the most important psychosocial target in cardiology 
research (Davidson et al., 2006; Rutledge et al., 2013).  
Mechanisms of Depression in CHD 
Although depression has been identified as a risk factor for the development of 
CHD, as well as an independent predictor of poor prognosis following cardiovascular 
events, the underlying mechanisms of these relations are still poorly understood (Carney 
& Freedland, 2008; Joynt et al., 2003; Skala et al., 2006). A number of studies have 
proposed and considered plausible mechanisms of a causal relationship between 
depression and CHD, yet there is little existing work to establish the etiological pathways 
by which depression contributes to adverse cardiac events and poorer prognosis. 
Candidate mechanisms that have been proposed to explain the link between depression 
and increased risk for CHD and subsequent cardiac mortality and morbidity broadly fall 
into one of two categories: physiological or behavioral processes. Based on the literature 
examining underlying mechanisms in depressed cardiac patients, Lett and colleagues 
(2004) proposed a theoretical biobehavioral model in which behavioral risk factors and 
physiological risk factors are interactive mechanisms that underlie the relation between 
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depression and CHD. Below, biological, behavioral, lifestyle, and social factors that 
represent potential mediating pathways are summarized in brief.  
Biological Mechanisms of Depression in CHD. Biological mechanisms are 
believed to partially explain the relation between depression and worse cardiac prognosis 
(Lett et al., 2004; Whooley et al., 2008). Studies have found disturbances in cardiac 
autonomic tone and decreased heart rate variability, an indicator of autonomic nervous 
system functioning, in depressed patients with stable coronary disease or a recent history 
of acute coronary syndrome (Carney & Freedland, 2008; Goldston & Baillie, 2008). 
Hyperactivity in the hypothalamic-pituitary-adrenocortical (HPA) system is believed to 
lead to overstimulation of the nervous system and subsequent neurohormonal 
abnormalities (Goldston & Baillie, 2008; Musselman, Evans, & Nemeroff, 1998). The 
combination of increased sympathetic stimulation and decreased parasympathetic control 
may explain the decreased heart rate variability and high risk of fatal arrhythmias 
displayed in depressed post-MI patients (Joynt et al., 2003). Increased platelet activation 
and thrombus formation is also an important pathogenic feature in MI and unstable 
angina, as supported by the therapeutic benefits of anticoagulant and fibrinolytic therapy 
(Braunwald et al., 2002; Gibbons et al., 2003, Joynt et al., 2003). Compared to 
nondepressed controls, depressed patients with CHD frequently exhibit higher levels of 
inflammatory biomarkers that predict cardiac events or promote atherosclerosis (Hasper 
et al., 1998; Koenig, 2001; Whooley et al., 2008); these include elevated 
proinflammatory cytokines such as C-reactive protein, interleukin-6, interleukin-1β, and 
tumor necrosis factor (Carney & Freedland, 2008; Rutledge et al., 2006). Recurrent 
endothelium damage may, in turn, trigger inflammatory processes that contribute to the 
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progression of atherosclerosis (Carney et al., 2002).  
Behavioral Mechanisms of Depression in CHD. Potential behavioral 
mechanisms linking depression and cardiovascular health include risk behaviors such as 
smoking, unhealthy diet, physical inactivity, and diminished compliance with medical 
regimens (Carney & Freedland, 2008; Goldston & Baillie, 2008; Lett et al., 2004). 
Empirical evidence supports depression as an independent predictor of adherence and 
participation in an exercise rehabilitation program, as well as depression as an 
independent predictor of improved cardiac functioning (Glazer, 2002; Kronish et al., 
2006). Additional research indicates that exercise training reduces cardiac and total 
mortality and improves cardiorespiratory fitness, psychological wellbeing, and quality of 
life (Dugmore et al., 1999; Taylor et al., 2004) in CHD patients. These studies lend 
empirical support to the relations between depression and treatment adherence, 
depression and cardiac outcomes, and treatment adherence and cardiac functioning.  
Few studies have examined adherence to behavioral recommendations as a 
mediator of the relation between depression and cardiac events or reduced 
cardiorespiratory fitness in patients with CHD. The Organization to Assess Strategies in 
Acute Ischemic Syndromes (OASIS) randomized controlled trial assessed 18,809 older 
adults from 41 countries with unstable angina or MI without ST-segment elevation and 
reported rates of adherence to physical activity (i.e., > 30 minutes, 3 times per week), 
dietary modifications (i.e., received counseling and reported compliance), and nicotine 
(i.e., less than one cigarette per day within the past month) guidelines 30 days following 
the index cardiac event (Chow et al., 2010). The authors found that 29.9% of patients 
adhered to both diet and exercise recommendations, whereas 41.6% demonstrated 
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adherence to either diet or exercise and 28.5% adhered to neither diet nor exercise 
recommendations. Furthermore, adherence to diet and exercise recommendations 30 days 
after the acute coronary event was associated with a 50% lower risk of recurrent 
cardiovascular events including MI, stroke, and death. In the Heart and Soul Study, a 
prospective study of 1,017 outpatients with CHD, physical activity (defined as 15-20 
minutes of moderately intense exercise, at least 3-4 times per month) was associated with 
a 31.7% reduction in the strength of association between depressive symptoms and 
cardiovascular events (Whooley et al., 2008). After adjusting for physical inactivity as a 
mediator, there was no longer a significant association between depression and adverse 
cardiovascular events. Although the results of the Heart and Soul Study provide 
preliminary evidence to suggest physical activity is a behavioral mediator of the relation 
between depression and cardiovascular events, there is little corroborating research to 
evidence treatment adherence in exercise-based rehabilitation specifically mediates the 
relation between depression and cardiac outcomes following treatment. The field needs to 
examine the additional risk reduction in adverse outcomes after the incorporation of 
secondary prevention strategies such as cardiac rehabilitation (Goldston & Baillie, 2008). 
Cardiac Rehabilitation (CR): Secondary Prevention  
Prior to the 1950s, the prescribed standard of care following MI consisted of bed 
rest and inactivity (Forman et al., 2000). Over the next few decades, however, CR 
developed into highly structured, physician-monitored exercise programs that eventually 
broadened to optimize cardiovascular risk modification and promote healthy lifestyles. 
Currently, CR is the established process by which cardiac patients undergo physical 
reconditioning and lifestyle training after acute MI, coronary revascularization, chronic 
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heart failure, cardiac transplantation, and other coronary events (Ades, 2001). The 
American Heart Association and the American Association of Cardiovascular and 
Pulmonary Rehabilitation publicly recognized CR as an integral part of comprehensive 
care of patients with cardiovascular disease (Balady, et al., 2007). Although some 
individual elements of CR may vary from program to program and between patients, the 
core components include prescribed exercise, medical evaluation, and coronary risk 
factor reduction (Wenger, 2008). Perhaps the most important element of CR is the 
individualized, structured, and progressive exercise program that needs to be continued 
long-term (Ades, 2001). Programs vary in length but generally consist of 24-36 sessions 
held 2-3 times weekly over 3-4 months (Wenger, 2008). The exercise portion of 
programs can be started safely as soon as 1-2 weeks following hospital discharge (Suaya, 
et al., 2009), allowing for initiation of the intervention soon after the cardiac event.  
Additional core elements of CR include education about secondary prevention 
guidelines and behavioral and pharmacological interventions designed to help patients 
develop and sustain lifestyle changes. Major topics include lipid and blood pressure 
control, behavioral weight management, nutrition counseling, physical activity and 
exercise training, smoking cessation, medication adherence, and management of 
psychosocial and emotional distress. A multidisciplinary team of rehabilitation providers 
(e.g., physician, nurse case manager, exercise physiologist, dietician, psychologist) is 
typically involved in monitoring clinical progress and reviewing short-term and long-
term risk reduction goals, as outlined by national guidelines (Balady et al., 2007).   
CR is a highly effective intervention for the secondary prevention of CHD. 
Numerous studies have demonstrated its effectiveness at reducing morbidity and 
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mortality rates following acute MI or coronary revascularization, while also reducing 
disability and promoting a healthy, active lifestyle (Clark et al., 2004; Suaya et al., 2009; 
Wenger, 2008). In a systematic review and meta-analysis of 48 randomized controlled 
trials comparing a structured exercise program to a usual care group, and a total sample 
of 8,940 patients with CHD (Taylor et al., 2004), CR was significantly associated with 
reduced all-cause mortality (OR = 0.80) and cardiac mortality (OR = 0.74) compared 
with usual medical care. The effect of CR on mortality was independent of diagnosis, 
type of CR, dose of exercise intervention, length of followup, trial quality, and trial 
publication date. A recent Cochrane review (Heran et al., 2011) of 47 studies examining 
the effectiveness of exercise-based CR (total N = 10,794 patients) found that CR was 
associated with reduced risk of overall mortality (RR = 0.87), cardiovascular mortality 
(0.74), and hospital admissions within 1 year of the acute coronary episode (RR = 0.69).  
CR offers a context within which to study the influence of depression on cardiac 
outcomes in patients with established heart disease. Exercise training in a CR setting 
improves cardiorespiratory fitness (Dugmore et al., 1999) in CHD patients. 
Cardiorespiratory fitness is typically captured via measures of maximal aerobic capacity 
during exercise tolerance testing, and has been identified as a quantitative predictor of all-
cause mortality and CHD in healthy patients (Kodama et al., 2009). In addition to 
reducing mortality and rehospitalization following coronary events, CR has been shown 
to successfully modify and target multiple risk factors (Taylor et al., 2004), including 
depression. In a meta-analysis examining the psychological effects of rehabilitation 
exercise programs in patients after an initial MI, with stable angina, or after bypass or 
valve operations (Kugler, Seelbach, & Krüskemper, 1994), 13 of 15 studies showed 
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participation in CR was associated with medium effects on both depression (d = .47) and 
anxiety (d = .31). A more recent meta-analysis of 13 CR studies found a small but 
significant effect size (d = 0.23) for improving depression severity (Rutledge et al., 
2013), with similar effects on depression, regardless of protocol length. Milani and Lavie 
(2007) retrospectively evaluated the impact of CR on depression and its associated 
mortality in a group of 522 patients who completed CR versus 179 patients who dropped 
out of CR within two weeks of entry and received fewer than five sessions. The 
prevalence of depressive symptoms decreased from 17% to 6% from entry to completion 
of the program in patients who completed CR. Depressed patients who completed CR 
also had a 73% lower mortality rate compared with depressed patients who did not 
complete CR.  
Clinical outcomes from CR trials have had a profound impact on national public 
health. In a total sample of 580 post-coronary event patients, 230 of whom entered an 
exercise and risk factor modification rehabilitation program, the effect of CR 
participation on medical costs was determined by measuring cardiac rehospitalization 
costs over a 3-year period (Ades, Huang, & Weaver, 1992). Per capita rehospitalization 
costs were $739 lower in CR participants than in nonparticipants over a 3-year period, 
and this difference between groups was explained by a lower incidence of 
hospitalizations and lower charges per hospitalization. Benefits were even greater for 
patients who completed rehabilitation. Another study examining cost effectiveness of CR 
in MI patients reported $4,950 per year of life saved (Ades, Pashkow, & Nestor, 1997). 
Treatment Adherence in CR 
 Although CR is widely recognized as an effective intervention in the secondary 
  16
prevention of CHD, CR services are vastly underutilized and overall rates of participation 
and treatment adherence remain quite low. Much of the literature in this area of research 
has examined CR participation, or the attendance of at least one CR session. A smaller 
body of literature has studied treatment adherence, that is, the total number of CR 
sessions attended. The majority of eligible individuals fail to attend CR altogether or drop 
out prematurely, with estimated rates of participation in a supervised structured CR 
program after a cardiovascular event ranging from 10% to 55% (CDC, 2003; Wenger, 
2008; Witt et al., 2004). Data collected from a 1990 survey of 500 CR programs (N = 
2,740) across the United States indicated that 10.8% of MI patients, 10.3% of CABG 
patients, and 23.4% of angioplasty patients enrolled in CR (Thomas et al., 1996). Another 
study utilizing Medicare claims to identify beneficiaries who had an index hospitalization 
in 1997 (N = 267,427) observed that CR was used by 13.9% of older adult patients 
hospitalized for MI and 31.0% of those who underwent CABG surgery (Suaya et al., 
2007). CR participants received, on average, 24 sessions (SD = 12). The same authors 
(Suaya et al., 2009) conducted a follow-up study to examine 1- to 5-year mortality rates 
in a wider sample of older patients with Medicare coverage who were hospitalized for 
coronary disease or revascularization procedures (N = 601,099). Mortality rates were 
21% to 34% lower in CR participants than in nonusers. Moreover, participants who 
completed at least 25 sessions were 19% less likely to die over 5 years compared to 
matched CR users who attended fewer than 25 sessions of CR. These statistics reinforce 
the utility and profound health benefits associated with CR adherence and completion. 
Many patient-related factors are likely to impede patient motivation and 
commitment to CR and measured outcomes. Women and older individuals tend to 
  17
present with greater needs in the context of more medical comorbidities and physical 
disability, which may contribute to their lower likelihood of participation in CR (Ades et 
al., 1992b; Suaya et al., 2007; Thomas et al., 1996; Witt et al., 2004). Contextual factors 
such as lower socioeconomic status, lower education, and minority status also tend to 
predict lower rates of participation (Ades & Gaalema, 2012; Suaya et al., 2009). 
Reluctance to commit to 8- to 12-week programs may be tied to logistic or financial 
impediments, or insufficient reimbursement of costs associated with CR (Suaya et al., 
2009). Other common reasons for reluctance or attendance problems may stem from 
beliefs related to the self, CHD, CR, other CR-attending patients, and health 
professionals’ knowledge base, or from feelings of embarrassment about group or public 
exercise (Clark et al., 2004).  
Depression as a Barrier to Treatment Adherence. Treatment adherence is an 
important clinical target in the secondary prevention of CHD. A meta-analysis of data on 
376,162 patients across 20 studies showed that approximately one-third of patients with a 
history of CHD did not adhere to drugs prescribed to prevent a secondary coronary event, 
whereas approximately half of those without CHD did not adhere to drugs prescribed to 
prevent a first event (Naderi, Bestwick, & Wald, 2012). A meta-analysis of the effects of 
depression and anxiety on treatment noncompliance found that depressed patients were 3 
times greater than non-depressed patients to be noncompliant with medical treatment 
recommendations (DiMatteo, Lepper, & Croghan, 2000). Treatment non-adherence is of 
even greater concern in the context of comorbid depression and CHD. Depression in 
cardiac patients tends to be persistent if left untreated (Hance et al., 1996) and is 
associated with medication adherence and adherence to other recommended health 
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behaviors (Gehi et al., 2005; Lespérance & Frasure-Smith, 2000; Pozuelo et al., 2009). In 
a study conducted by Rieckmann and colleagues (2006), adherence to aspirin therapy 
after MI was significantly lower in persistently depressed patients (76.1%) compared to 
patients whose depression improved (87.4%) and patients who were not depressed 
(89.5%).  
Depression severity and non-adherence also play a prominent role in the setting of 
secondary prevention and CR. In a sample of 348 patients with CHD enrolled in a 
comprehensive CR program, patients with a Beck Depression Inventory – II (BDI-II) 
score ≥ 14 showed a 5-fold increased risk of noncompletion (Caulin-Glaser et al., 2007). 
Prior research has demonstrated that elevated depressive symptoms and MDD following 
MI predicted poor self-reported adherence to recommended behavioral and lifestyle 
changes (e.g., low-fat diet, regular exercise, reducing stress, increasing social support) 4 
months after acute coronary syndrome (Ziegelstein et al., 2000). In a prospective 
longitudinal study of 560 cardiac patients, patients who exhibited persistent depression, 
defined by a BDI score ≥ 10 at hospitalization and 3 months later, reported lower rates of 
adherence in quitting smoking, taking medications, exercising, and attending CR 
compared with persistently nondepressed patients (Kronish et al., 2006).  
Another study examined the effects of depression and other psychological 
variables on adherence and physical functioning in a sample of 46 CHD patients during 
the first week and last week of a 12-week CR program (Glazer et al., 2002). The sample 
exhibited minimal levels of depression (Mean = 6.2, SD = 5.1), with only 10 participants 
reporting baseline scores on the BDI ≥ 10. Baseline depression accounted for 9.5% of the 
variance associated with change in maximum oxygen consumption (VO2max), a measure 
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of aerobic capacity, when controlling for relevant demographic variables and program 
attendance. These findings corroborate previously outlined research and affirm the 
significant influence of depression on adherence and functional improvement among 
cardiac patients. Given that depression predicts lower rates of participation in CR (Ades 
et al., 1992a; Kronish, et al., 2006) and poorer cardiovascular improvement (Glazer et al., 
2002), poor adherence to risk-reducing behaviors has been proposed as a potential 
mediator of the relationship between depression and poor long-term prognosis in patients 
after acute coronary syndrome (Kronish et al., 2006). 
The Current Study 
Collaboration across disciplines is recommended to establish clinical practice 
guidelines for CHD (Goldston & Baillie, 2008) within the context of CR (Rutledge et al., 
2013). The current project bridges cardiology and clinical health psychology and extends 
previous research on the effects of depression on behavioral and physiological 
cardiovascular health outcomes. More specifically, this project examines the impact of 
premorbid depression severity on treatment adherence in CR and cardiorespiratory fitness 
following CR. The theoretical model in Figure 1 is informed by biobehavioral theory 
(Lett et al., 2004) and tests the predictive value of baseline depression severity and CR 
attendance on cardiorespiratory fitness measures (e.g., VO2max, peak MET, duration of 
the exercise stress test) following a 12-week outpatient CR program.  
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Figure 1.  Proposed Structural Equation Model 
 
According to this novel theoretical model, CR attendance mediates the relation 
between baseline depression and cardiorespiratory fitness levels following CR. The major 
study hypotheses are as follows: (1) higher levels of baseline depression predict poorer 
cardiorespiratory fitness following CR completion; (2) higher levels of baseline 
depression predict lower rates of adherence to CR; (3) greater CR adherence (i.e., 
participation in more CR sessions) predict higher cardiorespiratory fitness; and (4) CR 
attendance significantly mediates the relation between baseline depression and 
cardiorespiratory fitness at post-CR while controlling for baseline fitness. The model 
takes into account the relation between depression and cardiorespiratory fitness at 
baseline as well as the relation between baseline and post-CR cardiorespiratory fitness 
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(i.e., the cross-time point within persons effect).  
Testing whether CR adherence mediates the relation between depression and 
cardiorespiratory fitness project holds implications for improving physical and mental 
health outcomes in cardiac patients with depression, as well as for treatment and 
prevention of depression in patients with CHD. The results of this project may inform 
nonpharmacological interventions and identify concrete behavioral targets (e.g., 
treatment adherence to CR) that may improve aerobic capacity and cardiovascular health. 
Further, CR programs may integrate evidence-based depression treatments to 
significantly impact public health. Thus, additional research in this area of study holds 
meaningful implications for improving treatment and quality of life for adults facing 
concomitant CHD and depression. The ultimate goal of this project is to offset the 
substantial cost and resources spent on individuals who suffer from concomitant cardiac 
disease and depression by improving early detection, assessment, and treatment.  
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CHAPTER 2: METHODS 
Participants  
Data for the current project were collected between 2011-2015 at the Cardiac 
Rehabilitation (CR) program at the University of Vermont Medical Center. Of note, the 
Geriatric Depression Scale was administered between 1996-2010 and subsequently 
replaced with the Patient Health Questionnaire Depression Scale (PHQ-9). Therefore, of 
the 2,526 patients in the full clinical database, only 858 patients (34.0%) provided valid 
data on the PHQ-9 and/or maximal exercise capacity for at least one time point (i.e., 
baseline “T1” and/or post-CR “T2”). Study participants were hospitalized at the 
University of Vermont Medical Center for an acute coronary event (e.g., angina, MI, 
coronary revascularization) and planned to enroll in the CR program after discharge. 
Exclusion criteria for CR enrollment included dementia (Mini Mental State Exam; 
MMSE < 20), exercise-limiting non-cardiac disease or longevity-limiting systemic 
disease that would preclude CR participation (e.g., advanced cancer, advanced frailty, 
severe arthritis, past stroke, severe lung disease).  
Table 1 shows the demographics and relevant medical variables for the study 
sample (N = 858). The mean age was 63.86 years (SD = 11.05). The sample was 74.4% 
male and 98.0% White. The distribution of coronary diagnosis and treatment during 
hospitalization was as follows: 36.4% MI (without CABG), 25.5% PCI, 20.7% CABG 
(with and without MI), 11.9% valve surgery, 1.7% CHF, 1.4% valve surgery and CABG, 
and 0.7% angina without surgery. Traditional modifiable risk factors for CHD were 
recorded upon enrollment into CR. The most common comorbid medical conditions were 
hypertension (63.6%) and Type 2 diabetes (21.6%).  
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Table 1.  
 
Descriptive Statistics for Categorical Sociodemographic and Medical Covariates 
 Frequency  
(N = 858) 
Percentage 
 
Gender 
     Male 638 74.4% 
     Female 220 25.6% 
Race 
     White 841 98.0% 
     African-American 7  0 .8% 
     Asian/Pacific Islander 2  0.2% 
     Hispanic 1   0.1% 
     Other 6   0.7% 
Diagnosis/Treatment 
     MI (no surgery) 312 36.4% 
     CABG (MI and no MI) 178 20.7% 
     PCI 219 25.5% 
     Valve surgery 102 11.9% 
     CHF 15 1.7% 
     CABG + Valve surgery 12 1.4% 
     Angina (no surgery) 6 0.7% 
Comorbid Medical Condition 
     Type 1 Diabetes Mellitus 7 0.8% 
     Type 2 Diabetes Mellitus 185 21.6% 
     Hypertension 548 63.6% 
Smoking Status 
     Current smoker 59   6.9% 
     Former smoker 445 51.9% 
     Never smoker 351 40.9% 
Medications 
     Aspirin 844 98.4% 
     Statins 768 89.5% 
     Beta blockers 700 81.6% 
     ACE inhibitors 443 51.6% 
     Calcium channel blockers 109 12.7% 
     Thyroid medications 65 7.6% 
     Nitrates 40 4.7% 
     Niacin 17 2.0% 
Note. MI = myocardial infarction, PCI = percutaneous coronary intervention, CHF = congestive 
heart failure, CABG = coronary artery bypass graft surgery, ACE inhibitors = angiotensin-
converting enzyme inhibitors 
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The majority of patients were current non-smokers (92.1%) and 40.9% of the sample 
reported never smoking. However, a significant smoking history was endorsed by more 
than half the sample, such that 51.9% identified as former smokers and 6.9% identified as 
current smokers. Prescription medications at baseline included aspirin (98.4%), statins 
(89.5%), beta blockers (81.6%), angiotensin-converting enzyme (ACE) inhibitors 
(51.6%), calcium channel blockers (12.7%), and thyroid medications (7.6%).  
Study Site 
Data collection for the current project took place at the outpatient Cardiac 
Rehabilitation Program affiliated with the University of Vermont Medical Center in 
South Burlington, Vermont. This facility served as the primary site for study recruitment, 
exercise testing, and on-site exercise training throughout the 12-week CR program. The 
facility was equipped with exercise training equipment (e.g., treadmills, ergometers, 
elliptical trainers, stair steppers, resistance training apparatus) and staffed by trained 
doctors, nurses, exercise physiologists, and physical therapists, under the direction of 
cardiologist, Philip A. Ades, M.D.  
Study Procedure  
Following hospitalization and treatment for the incident coronary event, patients 
deemed medically eligible for exercise-based intervention by their hospital treatment 
team were referred to the Cardiac Rehabilitation facility and program. The mean duration 
of time between hospitalization and entry into the CR program was 38.16 days (SD = 
28.54, median = 31 days). At their initial CR orientation visit, patients were provided 
informed consent about exercise testing and general CR procedures in a small group 
format and then taken on a tour of the facilities on site.  
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Exercise Stress Test. Following the group orientation visit and prior to initiating 
exercise training, all patients completed a medical evaluation with the Medical Director 
and performed a symptom-limited exercise tolerance test while taking medications as 
usual. Patients completed the exercise stress test again after the completion of the CR 
exercise-based intervention.   
The majority of patients completed a Balke (43.5%) or modified-Balke (33.7%) 
treadmill protocol upon entry into the study. During the test, exercise intensity was 
increased incrementally by 1 metabolic equivalent task (MET) in 2-minute intervals. A 
nuclear stress test protocol was used for a smaller subset of patients (17.9%) who 
required additional diagnostic testing for the purpose of guiding treatment; nuclear 
medicines (e.g., adenosine, dobutamine) were administered to measure blood flow to the 
heart at rest and upon exertion. A proportion of patients completed a different stress test 
protocol at T2. However, the same three protocols were most commonly performed post-
CR: Balke (32.8%), modified-Balke (23.4%), nuclear (9.6%).   
Across all protocol types, expired air was analyzed to determine peak oxygen 
consumption (VO2max) and carbon dioxide production with a metabolic cart. Exercise 
was ECG monitored and stopped prior to exhaustion if the patient developed progressive 
angina, > 2mm ST segment depression, exercise induced hypertension (230 systolic, 105 
diastolic), severe arrhythmias, dizziness or symptomatic hypotension. The occurrence of 
any untoward responses, other than high threshold angina, excluded a patient from the 
training protocol unless effective therapy was instituted. Test results included the 
patient’s peak heart rate (HR) and peak oxygen consumption (VO2max), two markers that 
were incorporated in designing a safe and individualized training regimen.  
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Exercise Intervention. The standard CR protocol consisted of three sessions per 
week for 12 weeks, for a maximum of 36 sessions. An individualized exercise-training 
program was designed for each CR patient based on the individual’s exercise stress test 
results (i.e., peak HR, VO2max). Other factors were considered when developing 
individualized exercise prescriptions; these included the patient’s familiarity with 
exercise, level of apprehension, personal goals, and medical co-morbidities. Four key 
components of exercise were carefully considered in providing exercise prescription, 
namely intensity, duration, frequency, and mode.  
Intensity. Typically, 70-85% of the patient’s peak HR from baseline testing was 
used to calculate an individual’s target HR zone. As patients improved their aerobic 
fitness, their exercise intensity was increased to maintain their exercise HR within the 
desired range. The training intensity was designed beneath the individual’s threshold for 
angina; however, the exact percentage of an individual’s peak HR that was prescribed 
varied. For significantly deconditioned patients, an intensity as low as 50-60% of 
maximal capacity may have been prescribed. Conversely, relatively fit individuals who 
were familiar with exercise may have been prescribed significantly higher intensities with 
approval from the Medical Director. During exercise sessions at the Cardiac 
Rehabilitation Facility, subjective ratings of perceived exertion (RPE) using the Borg 
Scale (i.e., ranging from “light” to “somewhat heavy;” Borg, 1982) were collected to 
capture the patient’s perceived level of exercise intensity.  
Duration. The initial duration of exercise was dictated primarily by an 
individual’s functional capacity. For severely deconditioned patients, multiple bouts of 
short duration were prescribed. Duration was then increased as the individual adapted to 
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training without adverse events and was able to maintain their prescribed intensity in 
regards to HR and/or RPE. Within a few weeks of starting CR, patients were typically 
able to exercise for 45 to 60 minutes. Highly motivated individuals who also benefited 
from high caloric expenditure exercise (i.e., overweight patients) were strongly 
encouraged to further increase exercise duration to promote weight loss. 
Frequency. Frequency is interrelated with fitness level, motivation, exercise 
intensity and duration. Patients were prescribed 2 to 3 onsite exercise sessions per week 
based on individual goals, availability, preferences, and physical limitations. Patients 
were further encouraged to exercise at least 1 to 2 times per week at home so that they 
were exercising a minimum of 3 to 5 days per week. Highly motivated and fit patients 
were asked to eventually exercise a total of 5 to 6 days per week as their exercise 
capacity increased. 
Mode. The mode of exercise was determined in part by personal preference, 
accessibility to equipment, fitness level, and physical capabilities. Exercise involving the 
use of large muscle groups was strongly encouraged. Often, multiple exercise modalities 
were used to protect against overuse injuries and to help condition a variety of muscle 
groups. Therefore, a range of aerobic exercise equipment was used, including treadmills, 
elliptical machines, rowing machines, cycling and arm ergometers, and stair climbers. 
Additionally, most individuals incorporated weight-training equipment at varying levels 
in order to increase muscular strength and endurance. 
As part of the CR program, participants also attended multiple educational 
sessions focused on stress management (five sessions), healthy nutrition (two sessions), 
medication use, symptom recognition, and the importance of risk factor control in 
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preventing future cardiac events. Smoking cessation was addressed in additional sessions 
using the five A’s model for treating tobacco use (Fiore, 2008). Long-term maintenance 
of the exercise program was recommended per standard clinical protocol.  
Measures 
Demographics and Medical History. Self-reported sociodemographic variables 
(e.g., age, gender, race) were collected at baseline, prior to exercise testing. Age and 
gender were examined as covariates, whereas race was not included as a covariate due to 
lack of heterogeneity in the current sample. Relevant medical health history (e.g., 
incident coronary event, medical procedure(s), current medications, comorbid medical 
conditions, smoking history) was collected during the medical evaluation that took place 
prior to initiating the exercise program.  
Patient Health Questionnaire Depression Scale (PHQ-9). The PHQ-9 is a brief 
screening instrument for depressive symptom severity that was administered to patients at 
baseline (Appendix 1). The PHQ-9 yields a provisional depression diagnosis in addition 
to a severity score that can be used for treatment selection and monitoring. The 9 primary 
items of the PHQ-9 are based on a 4-point Likert scale and ask the patient to rate how 
often each symptom of depression was experienced in the past two weeks (e.g., Not at all, 
Several days, More than half the days, Nearly every day). An additional item captures 
distress and functional impairment by having the respondent rate the level of difficulty 
associated with their depression symptoms in the context of work, home, and social 
relationships (e.g., Not difficult at all, Somewhat difficult, Very difficult, Extremely 
difficult). Patients with a total score ≥10 fall into the range of moderate to severe 
depression and should be referred for more comprehensive clinical evaluation by a 
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trained professional in the diagnosis and management of depression (Lichtman et al., 
2008). The PHQ-9 was designed for use in primary care and hospital settings because of 
its brief nature, and has been shown to be a reliable and valid measure of depression 
severity (Kroenke, Spitzer, & Williams, 2001). Moreover, this measure has been used in 
patients with CHD and other cardiovascular problems, and is a valid screening tool in the 
assessment and treatment of depression in this population (Gilbody et al., 2007; 
McManus, Pipkin, & Whooley, 2005; Stafford, Berk, & Jackson, 2007).  
CR Adherence and Completion Status. Participation in CR has most commonly 
been defined in the literature dichotomously, as attendance of at least 1 session or none. 
CR adherence, on the other hand, is typically conceptualized as a continuous variable and 
provides richer data about overall treatment engagement. CR adherence in this study was 
operationally defined as the total number of CR sessions attended; this value ranged from 
0 to 36. Due to external circumstances deemed unrelated to depression, some patients in 
the current sample could not complete the recommended 36 sessions. Secondary analyses 
were conducted to account for major factors that contributed to early termination of CR. 
One major limiting factor that affected CR attendance was approved coverage through 
the insurance provider. Some insurance plans covered only a restricted number of CR 
sessions (e.g., 3 to 18 sessions). Patients operating under this constraint were thus limited 
by external circumstances and were unable to complete 36 sessions of CR unless they 
paid out of pocket. It was important to distinguish these patients from others whose 
insurance plans covered 36 sessions but did not attend for other reasons. Another major 
problem with defining CR adherence by attendance arose for a group of patients who 
were deemed fit to return to work in fewer than 36 sessions due to their clinical 
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improvements and performance, most likely due to good treatment adherence. These 
patients were qualitatively different from other patients who were deemed unfit to return 
to work but chose to do terminate CR prematurely against provider recommendations. 
Due to these complicating factors in defining CR adherence by the total number of 
sessions attended, secondary analyses of the full mediation model considered “CR 
completion status,” a dichotomous variable that was broadly defined as whether the 
patient completed all possible sessions of CR. “Completers” included patients who 
completed fewer than 36 sessions if restricted solely by insurance coverage as well as 
patients who were deemed fit for early termination of CR by their case manager. 
Cardiorespiratory Fitness. Cardiorespiratory fitness was measured at both T1 
and T2 via three separate measures of maximal aerobic capacity: VO2max (mL/kg/min), 
peak MET, and duration of the exercise stress test (minutes). VO2max refers to the 
maximum volume or rate of oxygen consumption during exercise testing. This value is 
reached upon exertion of maximal effort and cardiac output, such that oxygen 
consumption plateaus despite an increase in workload. VO2max is considered the best 
index of cardiorespiratory fitness and accurate reflection of aerobic physical fitness and 
endurance capacity. Higher values correspond to greater cardiovascular fitness. 
Metabolic equivalents (METs) serve as a standard unit to measure and compare the 
intensity and expenditure of energy among persons of different weights. By convention, 
one MET is equivalent to the cost of 1 kcal/kg/hour (energy expenditure) or 3.5 
mL/kg/min (oxygen uptake) when sitting quietly. Peak MET in the current protocol was 
the maximum expenditure of energy required to complete the exercise stress test. Per test 
protocol, intensity was increased incrementally by 1 MET every 2 minutes. Higher values 
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are representative of better physical fitness. Duration of time (minutes) required to 
complete the exercise stress test was the final proxy for physical endurance and fitness. 
Longer duration of time was indicative of higher cardiorespiratory fitness, as participants 
were instructed to terminate upon fatigue. The majority of participants requested 
termination due to musculoskeletal fatigue and/or difficulty breathing.  
Data Analytic Plan 
Preliminary Analyses. Descriptive statistics for all major study variables and 
outcomes, including PHQ-9 total score, total number of CR sessions attended, and 
cardiorespiratory outcomes (e.g., VO2max, peak MET, duration of exercise stress test) 
were examined at both time points (i.e., baseline, post-CR). Bivariate correlations across 
the same study variables and time points were also calculated. Analysis of variance was 
used to examine depression group differences in sociodemographic characteristics, 
medical history, attendance in CR, and cardiorespiratory fitness pre-and post-CR.  
Primary Analyses. The current study aimed to test a theoretical model (Figure 1) 
in which baseline depression predicted post-CR cardiac fitness through CR adherence. 
Conducting an a priori power analysis to test the theoretical model was not possible, 
given that an existing clinical database was used. However, the data analytic plan 
emphasized effect sizes and bias-corrected confidence intervals and used multiple fit 
indices for assessment of model fit (Kline, 2011; Little, 2013). 
All models were tested with Mplus version 7.0 (Muthén & Muthén, 2010). 
Structural equation modeling was proposed to test model fit and to examine individual 
paths between major constructs in the model. To specifically test the indirect effect of 
baseline depression on cardiorespiratory fitness after rehabilitation through CR 
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adherence, standardized indirect effect parameters and bias-corrected bootstrap 
confidence intervals were estimated. Confidence intervals that did not contain zero 
reflected a statistically significant indirect effect.  
Measurement Model. A confirmatory factor analytic measurement model was 
first estimated in order to test fit of the factor structure of the “cardiorespiratory fitness” 
latent construct at T1 and T2 and to determine the factor loadings for each specified 
indicator (i.e., VO2max, peak MET, duration of the exercise stress test). The latent factors 
were allowed to freely vary and the following fit statistics were utilized to evaluate model 
fit: Comparative Fit Index (CFI; > .90 acceptable, > .95 excellent), Root Mean Square 
Error of Approximation (RMSEA; < .08 acceptable, < .05 excellent), and Standardized 
Root Mean Square Residual (SRMR; < .08 acceptable, < .05 excellent) (Browne & 
Cudeck, 1993; Hu & Bentler, 1999). The measurement model failed to obtain good fit (χ2 
(8) = 518.60, p = 0.000, CFI = 0.69, RMSEA = 0.27, 90% CI = 0.25 to 0.29, SRMR = 
0.10) such that the proposed structural model also displayed very poor fit (χ2 (25) = 
861.21, p = 0.000, CFI = 0.66, RMSEA = 0.20, 90% CI = 0.19 to 0.21, SRMR = 0.12); 
thus, path analysis was employed instead. 
Path Analysis. All cardiorespiratory fitness outcomes (i.e., VO2max, peak MET, 
duration of time until maximal capacity was reached on the exercise stress test) were 
treated as separate outcomes. More specifically, separate path models were run for each 
outcome. A total of three path models were run in which CR adherence was defined as 
the total number of attended CR sessions. Secondary analyses were conducted to account 
for external factors contributing to CR adherence. Path models were examined in which a 
probit regression was used to model the dichotomous outcome, CR completion status. 
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Lastly, another set of secondary path analyses were conducted to examine the same 
relations between depression, CR adherence and CR completion status, and 
cardiorespiratory fitness were modeled in a clinical subsample of depressed patients (n = 
74, patients with moderate to severe depression on the PHQ-9 with total score ≥ 10).  
Controlling for Confounding Factors. Coronary diagnosis, surgical procedure, 
and duration since the acute coronary event were collected at baseline. Traditional risk 
factors for CHD (e.g., diabetes mellitus, hypertension, smoking history) and common 
medications (e.g., beta blocker, ACE inhibitors) were coded in a binary fashion. Given 
that the above medical conditions and health behaviors increase cardiac risk, these 
confounding factors were accounted for with multiple-indicator/multiple-cause (MIMIC) 
models (Muthén, 1989), in which all major constructs at each time point in the final 
model were regressed on the covariates of interest. If paths in the model remained 
significant with the inclusion of a given variable, it was concluded that the variable did 
not influence the relations among variables in the model. 
Missing Data 
Missing data were treated as missing at random, and full information maximum 
likelihood estimation techniques were used for inclusion of all available data at each time 
point. For patients missing VO2max data, estimated values of VO2max were calculated 
based on the following regression equations derived from age, gender, and estimated 
METs (Ades, 2006).  
In men: VO2max = 26.89 – (0.20)(age) + (0.66)(estimated METs) 
In women: VO2max = 10.15 – (0.02)(age) + (1.11)(estimated METs) 
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CHAPTER 3: RESULTS 
Descriptive Statistics 
Measures of cardiorespiratory fitness at baseline and post-CR revealed that peak 
MET, VO2max, and duration of the exercise stress test increased over time (See Tables 
2a and 2b), thereby demonstrating patients broadly improved their aerobic capacity and 
fitness after participation in CR. Although there was considerable variability in the total 
number of attended sessions, overall CR adherence was relatively good in both the full 
sample (M = 24.70, SD = 12.55) and depressed sample (M = 23.74, SD = 13.02).  
The distribution of depression scores at baseline was highly skewed such that the 
vast majority of patients in the study sample reported minimal or subclinical depressive 
symptoms (M = 4.22, SD = 4.66). Only 74 patients (8.6%) screened positive for moderate 
to severe depression (i.e., PHQ-9 total score ≥ 10). Descriptive statistics for 
sociodemographic and relevant medical variables are presented separately for the entire 
sample (N = 858) and the clinical subsample (n = 74) in Tables 2a and 2b, respectively.  
The subsample of 74 patients who reported elevated depressive symptoms were 
younger in age (59.93 ± 1.37) compared to patients who reported subclinical depression 
(64.41 ± 0.46; t(630) = 3.32, p = 0.001). There were notable group differences in medical 
history such that the depressed subsample was more likely to carry a diagnosis of Type 2 
diabetes (χ2 (1) = 4.85, p = 0.03) and take ACE inhibitors (χ2 (1) = 3.76, p = 0.05). The 
groups were otherwise comparable on gender, race, diagnosis, and duration of time 
between the incident coronary event and initiating CR. The depressed group showed 
poorer cardiorespiratory fitness at baseline according to measures of VO2max (t(614) = 
3.29, p = 0.001) and peak MET (t(614) = 3.98, p < 0.001) compared to the non-depressed 
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group. However, there were no depression group differences in measures of 
cardiorespiratory fitness post-CR, CR attendance, or CR completion status based on 
baseline depression severity. Due to the significant group differences that emerged 
according to depression severity, secondary path analyses were conducted to explore the 
impact of baseline depression on treatment adherence and cardiorespiratory fitness in the 
clinical subsample. 
Table 2a.  
 
Descriptive Statistics for Continuous Sociodemographic Covariates and 
Cardiorespiratory Fitness Outcomes in Full Sample (N = 858) 
 
 N Min Max Mean SD 
Age (years) 858 20 94 63.86 11.05 
Duration after 
coronary event 
(days) 
841 5 300 38.16 28.54 
PHQ-9 T1 632 0 26 4.22 4.66 
Total CR sessions 
attended 
856 0 36 24.70 12.55 
Peak MET T1 830 0 14 6.03 2.29 
Peak MET T2 594 2.00 20.60 7.63 2.80 
VO2max T1 
(mL/kg/min) 
830 8.10 43.40 18.92 5.87 
VO2max T2 
(mL/kg/min) 
594 7.00 48.30 22.32 6.97 
Duration of stress 
test T1 (min) 
820 1.00 18.00 7.49 2.68 
Duration of stress 
test T2 (min) 
588 3.00 24.00 10.09 2.88 
 
Note: T1 = Time 1 (baseline), T2 = Time 2 (post-CR)
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Table 2b.  
 
Descriptive Statistics for Continuous Sociodemographic Covariates and 
Cardiorespiratory Fitness Outcomes in Depressed Subsample (n = 74) 
 
 N Min Max Mean SD 
Age (years) 74 20 86 59.93 11.76 
Duration after 
coronary 
event (days) 
71 15 210 45.54 31.17 
PHQ-9 T1 74 10 26 14.36 4.16 
Total attended 
CR sessions 
74 0 36 23.74 13.02 
Peak MET T1 72 0.00 10.03 4.86 1.83 
Peak MET T2 39 2.00 14.00 6.80 2.51 
VO2max T1 
(mL/kg/min) 
72 8.50 35.10 17.22 5.33 
VO2max T2 
(mL/kg/min) 
39 7.00 42.00 20.52 6.90 
Duration of 
stress test T1 
(min) 
70 1.50 14.00 6.74 2.71 
Duration of 
stress test T2 
(min) 
40 3.00 18.00 9.19 3.03 
  
Note: T1 = Time 1 (baseline), T2 = Time 2 (post-CR) 
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Bivariate Correlations 
Table 3 presents the bivariate correlations between all continuous variables in the 
theoretical model. All bivariate combinations of cardiorespiratory fitness outcomes at T1 
and T2 were moderately or highly correlated. Cross-time point correlations for VO2max 
(r = 0.89), peak MET (r = 0.84), and duration of stress test (r = 0.63) at T1 and T2 were 
strongly correlated (p < 0.01). Baseline depression showed a weak negative correlation 
with all cardiorespiratory fitness indices, with the exception of peak MET at T2 (ns). 
There was a weak inverse correlation between the total number of attended CR sessions 
and cardiorespiratory measures at both T1 and T2, whereas there was no association 
between baseline depression and the total number of CR sessions.  
Path Analysis: CR Attendance (N = 858) 
Because the theoretical model could not be tested in the full sample due to poor 
model fit, path analyses were run separately for each outcome variable of interest (i.e., 
VO2max, peak MET, duration of exercise stress test). In accordance with bivariate 
correlational data, stability paths were significant across all cardiorespiratory fitness 
indicators, and baseline depression was significantly associated with each measure of 
fitness at baseline. Refer to Figures 2a, 2b, and 2c for visual representation of the path 
models. Path estimates are presented in Tables 4a, 4b, and 4c. Baseline VO2max 
significantly predicted post-CR VO2max levels (β = 0.89, SE = 0.01, 90% CI 0.86 to 
0.91, p < 0.001). Baseline peak MET also significantly predicted peak MET following 
CR participation (β = 0.85, SE = 0.02, 90% CI 0.82 to 0.88, p < 0.001). Baseline stress 
test duration significantly predicted duration of the post-CR stress test (β = 0.61, SE = 
0.03, 90% CI 0.56 to 0.67, p < 0.001). 
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Baseline depression was also significantly associated with VO2max (β = -0.16, SE 
= 0.04, CI -0.23 to -0.08, p < 0.001), peak MET (β = -0.17, SE = 0.04, CI -0.25 to -0.09, 
p < 0.001), and duration of the exercise stress test (β = -0.11, SE = 0.05, CI -0.20 to -
0.02, p < 0.05) at baseline. However, the three models failed to show good fit for the 
following separate outcomes at post-CR: VO2max (χ2 (1) = 25.08, p = 0.000, CFI = 0.96, 
RMSEA = 0.17, 90% CI = 0.12 to 0.23, SRMR = 0.06), peak MET (χ2 (1) = 18.10, p = 
0.000, CFI = 0.97, RMSEA = 0.14, 90% CI = 0.09 to 0.20, SRMR = 0.05), and duration 
of the exercise stress test (χ2 (1) = 10.70, p = 0.001, CFI = 0.96, RMSEA = 0.11, 90% CI 
= 0.06 to 0.17, SRMR = 0.04). Thus, contrary to original hypotheses, CR attendance did 
not significantly mediate the relations between baseline depression and VO2max, peak 
MET, or duration of the stress test following CR.  
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Figure 2a. Path Analysis for VO2max  
 
 
Figure 2b. Path Analysis for Peak MET  
 
 
Figure 2c. Path Analysis for Stress Test Duration  
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Table 4a.  
 
Path Analysis for VO2max 
Estimated Path β SE 95% CI p 
VO2max(T1) – VO2max(T2) 0.89 0.01 0.86 to 0.91 <0.001 
CR – VO2max(T2) 0.02 0.03 -0.04 to 0.07 0.515 
Dep(T1) – VO2max(T2) -0.01 0.03 -0.07 to 0.03 0.663 
Dep(T1) – CR -0.04 0.04 -0.12 to 0.03 0.376 
VO2max(T1) – Dep(T1) -0.16 0.04 -0.23 to -0.08 <0.001 
 
Table 4b.  
 
Path Analysis for Peak MET 
Estimated Path β SE 95% CI p 
MET(T1) – MET(T2) 0.85 0.02 0.82 to 0.88 <0.001 
CR – MET(T2) 0.04 0.03 -0.02 to 0.10 0.186 
Dep(T1) – MET(T2) 0.00 0.03 -0.06 to 0.05 0.930 
Dep(T1) – CR -0.04 0.04 -0.12 to 0.04 0.386 
MET(T1) – Dep(T1) -0.17 0.04 -0.25 to -0.09 0.001 
 
Table 4c.  
 
Path Analysis for Duration of Stress Test 
Estimated Path β SE 95% CI p 
Duration(T1) – Duration(T2) 0.61 0.03 0.56 to 0.67 <0.001 
CR – Duration(T2) 0.02 0.04 -0.06 to 0.11 0.570 
Dep(T1) – Duration(T2) -0.06 0.05 -0.15 to 0.03 0.201 
Dep(T1) – CR -0.04 0.04 -0.12 to 0.04 0.282 
Duration(T1) – Dep(T1) -0.11 0.05 -0.20 to -0.02 0.018 
 
Note. T1 = Time 1 (baseline), T2 = Time 2 (post-CR), CR = total number of exercise sessions 
attended in 12-week Cardiac Rehab program, VO2max = maximum oxygen consumption 
(mL/kg/min) during exercise stress test, MET = peak MET attained during exercise stress test, 
Duration = duration of time (minutes) to complete the exercise stress test 
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Path Analysis: CR Completion Status (N = 858) 
Figures 3a, 3b, and 3c depict path models in which CR completion (i.e., whether 
the patient completed the maximum number of CR sessions available as determined by 
the case manager and/or insurance limitations) was considered in lieu of CR attendance. 
To account for the categorical outcome of completion status, a probit regression with 
weighted least squares estimation was conducted in secondary path analyses. Refer to 
Tables 5a, 5b, and 5c for path estimates. Interestingly, only one model in which duration 
of the stress test was the primary cardiorespiratory fitness outcome emerged with 
excellent fit statistics. Figure 3c illustrates the path model in which duration of the 
exercise stress test was the primary outcome (χ2 (1) = 2.98, p = 0.08, CFI = 0.99, RMSEA 
< 0.05, 90% CI = 0.00 to 0.12). The stability path between baseline (T1) and post-CR 
(T2) for duration of time to complete the baseline stress test was highly significant (β = 
0.62, SE = 0.02, 90% CI 0.58 to 0.65, p < 0.001). Baseline depression significantly 
predicted CR completion, whereby higher depression scores were associated with a lower 
likelihood of completing CR (β = -0.12, SE = 0.05, 90% CI -0.22 to -0.02, p < 0.05). 
Baseline depression was also inversely associated with stress test duration at baseline (β 
= -0.12, SE = 0.04, CI -0.19 to -0.04, p < 0.01). The significant paths summarized above 
were largely unaffected by the inclusion of covariates, with one minor exception; CR 
completion was associated with a longer duration of time to reach maximal aerobic 
capacity on the exercise stress test post-CR when controlling for age (β = 0.08, SE = 
0.04, CI 0.01 to 0.15, p < 0.05).
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Figure 3a. Path Analysis for VO2max  
 
Figure 3b. Path Analysis for Peak MET 
  
 
Figure 3c. Path Analysis for Stress Test Duration   
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Table 5a.  
 
Path Analysis for VO2max 
Estimated Path β SE 95% CI p 
VO2max(T1)  VO2max(T2) 0.89 0.01 0.87 to 0.91 <0.001 
CR  VO2max(T2) -0.14 0.05 -0.21 to -0.08 <0.001 
Dep(T1)  VO2max(T2) 0.01 0.04 -0.08 to 0.07 0.911 
Dep(T1)  CR -0.12 0.05 -0.21 to -0.02 0.020 
VO2max(T1)  Dep(T1) -0.16 0.04 -0.24 to -0.08 <0.001 
 
Table 5b.  
 
Path Analysis for Peak MET 
Estimated Path β SE 95% CI p 
MET(T1)  MET(T2) 0.86 0.01 0.82 to 0.88 <0.001 
CR  MET(T2) -0.09 0.04 -0.17 to -0.01 0.021 
Dep(T1)  MET(T2) 0.05 0.05 -0.05 to 0.15 0.360 
Dep(T1)  CR -0.11 0.05 -0.21 to -0.02 0.022 
MET(T1)  Dep(T1) -0.17 0.04 -0.25 to -0.08 <0.001 
 
Table 5c.  
 
Path Analysis for Duration of Stress Test 
Estimated Path β SE 95% CI p 
Duration(T1)  Duration(T2) 0.62 0.02 0.58 to 0.65 <0.001 
CR  Duration(T2) -0.03 0.04 -0.12 to 0.06 0.477 
Dep(T1)  Duration(T2) -0.06 0.05 -0.15 to 0.04 0.258 
Dep(T1)  CR -0.12 0.05 -0.22 to -0.02 0.016 
Duration(T1)  Dep(T1) -0.12 0.04 -0.19 to -0.04 0.002 
 
Note. T1 = Time 1 (baseline), T2 = Time 2 (post-CR), CR = completer status in the 12-week 
Cardiac Rehab program, VO2max = maximum oxygen consumption (mL/kg/min) during exercise 
stress test, MET = peak MET attained during exercise stress test, Duration = duration of time 
(minutes) to complete the exercise stress test 
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Path Analysis: CR Attendance (n = 74, Depressed Subsample) 
Secondary path analyses explored the effects of depression severity on CR 
adherence and cardiorespiratory fitness in 74 patients with moderate to severe depressive 
symptoms at baseline. The same series of path analyses conducted using the full sample 
was re-run in the clinical subsample. Refer to Figures 4a, 4b, 4c to visualize the models 
in which VO2max (χ2 (1) = 0.03, p = 0.86, CFI = 1.00, RMSEA < 0.001, 90% CI = 0.00 
to 0.17, SRMR = 0.01), peak MET (χ2 (1) = 0.16, p = 0.69, CFI = 1.00, RMSEA < 0.001, 
90% CI = 0.00 to 0.23, SRMR = 0.01), and duration of the exercise stress test (χ2 (1) = 
0.21, p = 0.65, CFI = 1.00, RMSEA < 0.001, 90% CI = 0.00 to 0.24, SRMR = 0.02) 
represent indicators of cardiorespiratory fitness. All three models showed excellent fit 
and were thus interpreted. Table 6a, 6b, and 6c display the path estimates for each model. 
The stability paths were highly significant in each model. VO2max at baseline (T1) 
predicted VO2max at post-CR (T2) (β = 0.85, SE = 0.05, 90% CI 0.75 to 0.95, p < 0.001); 
peak MET at T1 predicted peak MET at T2 (β = 0.76, SE = 0.07, 90% CI 0.62 to 0.90, p 
< 0.001); and stress test duration at T1 predicted stress test duration at T2 (β = 0.55, SE = 
0.09, 90% CI 0.38 to 0.72, p < 0.001). Baseline depression significantly predicted CR 
attendance across all three models, whereby higher depression scores were associated 
with lower CR attendance (β = -0.23, SE = 0.11, 90% CI -0.45 to -0.02, p < 0.05). No 
additional significant pathways emerged. MIMIC models demonstrated that all pathways 
were largely unaffected by demographic and medical covariates. 
Path Analysis: CR Completion Status (n = 74, Depressed Subsample) 
Secondary path analyses considered CR completion status in place of CR 
attendance in the clinically depressed subsample. Again, all three models showed 
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excellent fit for the following separate outcomes at post-CR: VO2max (χ2 (1) = 0.11, p = 
0.74, CFI = 1.00, RMSEA = 0.00, 90% CI = 0.00 to 0.11), peak MET (χ2 (1) = 2.00, p = 
0.16, CFI = 0.99, RMSEA = 0.06, 90% CI = 0.00 to 0.18), and duration of the stress test 
(χ2 (1) = 2.40, p = 0.12, CFI = 0.98, RMSEA = 0.07, 90% CI = 0.00 to 0.18).  See Figures 
5a, 5b, and 5c and Tables 7a, 7b, and 7c for corresponding data. Stability paths between 
VO2max (β = 0.88, SE = 0.01, 90% CI 0.86 to 0.91), peak MET (β = 0.86, SE = 0.02, 
90% CI 0.83 to 0.90), and duration of the stress test (β = 0.62, SE = 0.04, 90% CI 0.56 to 
0.69) were significant (p < 0.001). No additional significant pathways emerged for 
models in which peak MET and duration of the stress test represented cardiorespiratory 
fitness. However, when VO2max was the primary fitness outcome in the model, CR 
completion significantly and negatively predicted fitness at post-CR (β = -0.27, SE = 
0.07, 90% CI    -0.40 to -0.14, p < 0.001). These pathways were not affected by the 
inclusion of covariates in MIMIC models. 
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Figure 4a. Path Analysis for VO2max in the Depressed Subsample 
 
 
Figure 4b. Path Analysis for Peak MET in the Depressed Subsample 
 
 
Figure 4c. Path Analysis for Duration of Stress Test in the Depressed Subsample 
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Table 6a.  
 
Path Analysis for VO2max in the Depressed Subsample 
Estimated Path β SE 95% CI p 
VO2max(T1)  VO2max(T2) 0.85 0.05 0.75 to 0.95 <0.001 
CR  VO2max(T2) 0.17 0.20 -0.22 to 0.56 0.392 
Dep(T1)  VO2max(T2) -0.06 0.10 -0.26 to 0.14 0.570 
Dep(T1)  CR -0.23 0.11 -0.45 to -0.02 0.033 
VO2max(T1)  Dep(T1) 0.03 0.12 -0.21 to 0.26 0.823 
 
Table 6b.  
 
Path Analysis for Peak MET in the Depressed Subsample 
Estimated Path β SE 95% CI p 
MET(T1)  MET(T2) 0.76 0.07 0.62 to 0.90 <.001 
CR  MET(T2) -0.03 0.31 -0.63 to 0.57 0.919 
Dep(T1)  MET(T2) -0.14 0.14 -0.42 to 0.14 0.318 
Dep(T1)  CR -0.23 0.11 -0.45 to -0.02 0.033 
MET(T1)  Dep(T1) 0.10 0.12 -0.14 to 0.33 0.434 
 
Table 6c.  
 
Path Analysis for Duration of Stress Test in the Depressed Subsample 
Estimated Path β SE 95% CI p 
Duration(T1)  Duration(T2) 0.55 0.09 0.38 to 0.72 <.001 
CR  Duration(T2) 0.21 0.27 -0.32 to 0.74 0.441 
Dep(T1)  Duration(T2) 0.03 0.14 -0.25 to 0.31 0.841 
Dep(T1)  CR -0.23 0.11 -0.45 to -0.02 0.033 
Duration(T1)  Dep(T1) -0.03 0.13 -0.28 to 0.22 0.826 
 
Note. T1 = Time 1 (baseline), T2 = Time 2 (post-CR), CR = total number of exercise sessions 
attended in Cardiac Rehab 12-week program, VO2max = maximum oxygen consumption 
(mL/kg/min) during exercise stress test, MET = peak MET attained during exercise stress test, 
Duration = duration of time (minutes) to complete the exercise stress test
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Figure 5a. Path Analysis for VO2max in the Depressed Subsample 
  
 
Figure 5b. Path Analysis for Peak MET in the Depressed Subsample 
  
 
Figure 5c. Path Analysis for Duration of Stress Test in the Depressed Subsample 
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Table 7a.  
 
Path Analysis for VO2max in the Depressed Subsample 
Estimated Path β SE 95% CI p 
VO2max(T1)  VO2max(T2) 0.88 0.01 0.86 to 0.91 <0.001 
CR  VO2max(T2) -0.27 0.07 -0.40 to -0.14 <0.001 
Dep(T1)  VO2max(T2) -0.02 0.13 -0.27 to 0.23 0.854 
Dep(T1)  CR -0.18 0.12 -0.41 to 0.04 0.113 
VO2max(T1)  Dep(T1) 0.03 0.10 -0.18 to 0.23 0.776 
 
Table 7b.  
 
Path Analysis for Peak MET in the Depressed Subsample 
Estimated Path β SE 95% CI p 
MET(T1)  MET(T2) 0.86 0.02 0.83 to 0.90 <0.001 
CR  MET(T2) -0.07 0.10 -0.26 to 0.12 0.444 
Dep(T1)  MET(T2) 0.06 0.17 -0.27 to 0.39 0.716 
Dep(T1)  CR -0.19 0.12 -0.42 to 0.04 0.100 
MET(T1)  Dep(T1) 0.02 0.10 -0.18 to 0.22 0.868 
 
Table 7c.  
 
Path Analysis for Duration of Stress Test in the Depressed Subsample 
Estimated Path β SE 95% CI p 
Duration(T1)  Duration(T2) 0.62 0.04 0.56 to 0.69 <0.001 
CR  Duration(T2) 0.03 0.10 -0.17 to 0.24 0.759 
Dep(T1)  Duration(T2) 0.05 0.19 -0.31 to 0.41 0.790 
Dep(T1)  CR -0.18 0.12 -0.40 to 0.05 0.124 
Duration(T1)  Dep(T1) -0.03 0.10 -0.23 to 0.17 0.784 
 
Note. T1 = Time 1 (baseline), T2 = Time 2 (post-CR), CR = completion status in the 12-week 
Cardiac Rehab program, VO2max = maximum oxygen consumption (mL/kg/min) during exercise 
stress test, MET = peak MET attained during exercise stress test, Duration = duration of time 
(minutes) to complete the exercise stress test 
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CHAPTER 4: DISCUSSION 
In order to reduce major depression and coronary heart disease, the two leading 
causes of death and disability, researchers in behavioral cardiology should strive to 
understand the mechanisms through which depression contributes to CHD and cardiac 
functioning. The current project draws upon biobehavioral theory (Lett et al., 2004) and 
tests the hypothesis that CR adherence is a behavioral mechanism through which 
depression indirectly predicts cardiorespiratory fitness. Findings from this study 
contribute uniquely to a growing body of literature on depression and cardiovascular 
health, and hold important clinical implications for older adults following a coronary 
event. 
In summary, the major significant findings from the current study support the 
hypothesis that baseline depression significantly predicts CR adherence. More 
specifically, higher levels of baseline depression predicted lower CR attendance in a 
subsample of clinically depressed patients, whereas in the full sample of both depressed 
and non-depressed patients, those with more severe depression at baseline were more 
likely to be non-completers of CR. Given that the measurement model failed to obtain 
good fit, we can conclude that VO2max, peak MET, and duration of the stress test did not 
map onto the same underlying construct “cardiorespiratory fitness,” as predicted. 
Furthermore, contrary to initial hypotheses: (1) higher levels of baseline depression did 
not predict poorer cardiorespiratory fitness following CR; (2) CR adherence (i.e., 
attending more sessions) did not predict higher cardiorespiratory fitness post-CR; and (3) 
CR attendance did not significantly mediate the relation between baseline depression and 
cardiorespiratory fitness post-CR.  
  52
Measures of Cardiorespiratory Fitness 
Taken as a whole, study results provide empirical evidence that VO2max, peak 
MET, and duration of the exercise stress test are unique fitness outcomes of exercise in 
CR. Given that the proposed structural equation model (Figure 1) failed to obtain good 
fit, these indicators may not map onto the same underlying construct. Future studies 
should further test the cardiorespiratory fitness latent construct and consider alternative 
indicators to VO2max, peak MET, and duration of the exercise stress. However, for the 
purposes of this study, we will continue to refer to VO2max, peak MET, and duration of 
the exercise stress test as cardiorespiratory fitness outcomes. 
Path Analyses in the Full Sample: CR Attendance and CR Completion 
The main study hypotheses about relations between baseline depression, CR 
adherence (i.e., total number of exercise sessions attended), and cardiorespiratory fitness 
were tested via a series of path analyses. VO2max, peak MET, duration of the maximal 
exercise stress test were treated as individual outcomes in three separate models. 
Contrary to hypothesis, all three models showed poor statistical fit and were not 
interpreted. Secondary analyses were conducted in which CR attendance was replaced by 
CR completion (i.e., a dichotomous variable that accounted for external factors that 
limited CR attendance, such as limited insurance coverage or early termination due to 
good clinical progress). The model in which duration of the stress test was the primary 
indicator of cardiorespiratory fitness showed good fit, suggesting that CR completion 
status, or alternative constructs to attendance or adherence, are important to consider 
when examining relations between depression severity and cardiorespiratory fitness pre- 
and post-CR.  
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Additionally, the interpretable model showed that baseline depression severity on 
the PHQ-9 predicted CR completion, but not attendance. Higher levels of depression 
predicted early termination of CR whereas lower levels of depression predicted CR 
completion. Depression was also negatively associated with baseline measures of peak 
MET and total duration of the exercise stress test. These significant findings are in line 
with literature concluding baseline depression severity is a predictor of lower rates of CR 
participation (Ades et al., 1992a) and completion (Caulin-Glaser et al., 2007) as well as 
research showing an inverse relation between depression symptom severity and 
cardiorespiratory fitness (Galper et al., 2006; Papasavvas et al., 2015). One possible 
explanation for the negative relation between depression severity and CR adherence is 
that depressed individuals may be less motivated to engage in physical activity than non-
depressed individuals and, therefore, may have shown reduced attendance. Alternatively, 
depressed CHD patients may tolerate a lower threshold of fatigue due to increased 
somatic symptoms of depression, which may result in reduced CR attendance.  
Contrary to prediction, both baseline depression severity and CR completion did 
not predict cardiorespiratory fitness outcomes post-CR. Consequently, CR adherence did 
not mediate the relation between baseline depression and cardiorespiratory fitness after 
CR. These non-significant findings were surprising given that prior studies have 
evidenced a dose-response relationship between depression and cardiorespiratory fitness 
(Glazer et al., 2002) and between participation in exercise rehabilitation and post-CR 
aerobic capacity (Dugmore et al., 1999). 
There are a number of possible explanations for the non-significant path estimates 
in the aforementioned path models. First, the stability path estimates for cardiorespiratory 
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fitness measures between baseline and post-CR were large (e.g., β = .85 for peak MET 
and β = .61 for duration of stress test between time points), indicating that maximal 
aerobic capacity at baseline was a very good predictor of the same outcome post-CR. The 
size of the stability path estimate accounted for the majority of variance, thus leaving 
little remaining variance in the model and making it difficult to detect other significant 
path relations. Second, there was a small inverse correlation between CR attendance and 
all three measures of cardiorespiratory fitness following CR, which likely impacted the 
relation between CR attendance and cardiorespiratory fitness post-CR. Although the 
directionality of the bivariate correlation is surprising at face value, this can at least 
partially be explained by certain external factors (e.g., approval to terminate the program 
prematurely due to good clinical progress, limited insurance coverage) that reduced 
attendance in patients who otherwise showed good treatment adherence. This 
interpretation provides additional support for the secondary analyses in which CR 
adherence was replaced by CR completion status.  
Path Analyses in the Depressed Subsample 
Given that the study sample was predominantly comprised of non-depressed 
individuals (91.4%), the path model results were likely influenced by the highly skewed 
depression scores in the full sample. Therefore, secondary path analyses were conducted 
in a smaller subset of patients (n = 74) who scored above a clinical cut-point on the PHQ-
9 indicating moderate to severe levels of depression. Interestingly, when the same path 
models were tested in the depressed subsample, all six models showed excellent fit 
statistics and were therefore interpreted. As predicted, higher levels of baseline 
depression predicted lower CR attendance. This is consistent with previous research 
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indicating higher levels of depressive symptoms predict poorer CR adherence (Kronish et 
al., 2006; Ziegelstein et al., 2000), thus providing further evidence that depression is a 
risk factor for poor treatment adherence after acute coronary syndrome.  
Unlike results for the full sample, baseline depression did not predict CR 
completion in the subsample of clinically depressed patients. Contrary to hypothesis, 
baseline depression also did not predict cardiorespiratory fitness outcomes in the 
depressed sample. There was a significant relation between CR completion and post-CR 
VO2max, suggesting that patients who completed the CR program exhibited higher levels 
of cardiorespiratory fitness. However, this may be a spurious finding as no similar 
findings emerged within the other path models. According to the path models, CR 
completion did not mediate the relation between baseline depression and each of the 
cardiorespiratory fitness outcomes. Similar to what was discussed above for the full 
sample results, the stability path estimates for VO2max, peak MET, duration of the 
exercise stress test were large (e.g., β = .85 between VO2max at T1 and T2; β = .77 
between peak MET at T1 and T2; β = 0.55 between duration of stress test between T1 
and T2), thus leaving little variance to detect other significant path relations in the 
models.  
Clinical Implications 
The current study concludes that patients who enter CR with higher depression 
scores are more likely to prematurely drop out of CR, the gold standard treatment in the 
secondary prevention of CHD. Nonadherence to CR coincides with other modifiable risk 
factors (e.g., quitting smoking, taking medications regularly; Kronish et al., 2006) and 
places patients at greater risk of rehospitalization and cardiac mortality. Furthermore, 
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patients with moderate and severe levels of depression show poorer attendance in CR. As 
previously discussed, depression is a major contributor to lower quality of life and 
increased healthcare costs for CHD patients. Thus, clinical implications of the current 
study pertain to treatment and prevention of concomitant CHD and depression.  
Findings from the current study underscore the importance of screening and 
treating depression in the aftermath of hospitalization for an acute coronary event and 
more broadly in the secondary prevention of cardiovascular events. Compared to the 
estimated point prevalence of depression in CHD patients (20%; Lichtman et al., 2008; 
Thombs et al., 2005), a much smaller proportion (8.6%) of patients in the current sample 
screened positive for depression on the PHQ-9. This likely reflects a large proportion of 
patients who did not follow up with physician referrals to CR after hospitalization and 
never attended CR orientation; the low rate of clinical depression in the current CR 
sample may be directly related to baseline depression and/or motivational factors. Thus, 
the window of time between acute hospitalization and the weeks immediately following 
discharge represents a critical period during which patients should be screened for 
depression and provided psychoeducation about managing heart disease, emotional 
stress, and risk factors. Psychological coping skills and evidence-based treatments for 
depression may also be introduced, as needed, during this critical window before 
discharge. Both hospitals and outpatient CR programs may benefit from staffing trained 
behavioral health consultants who can assess depression, triage mental health concerns, 
and enhance patient motivation to engage in CR and modify lifestyle factors. 
There are three broad categories of depression treatment that have been applied to 
depression in the context of CHD: pharmacological, psychological, and exercise-based 
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interventions. Selective serotonin reuptake inhibitors (SSRIs) are considered the safest 
form of antidepressants for CHD patients (Kronish et al., 2012), with sertraline and 
citalopram among the front-line prescriptions that have demonstrated efficacy in the 
treatment of moderate, severe, or recurrent depression (Glassman et al., 2002; Lespérance 
et al., 2007; Lichtman et al., 2008). According to a meta-analysis of 16 antidepressant 
trials (Baumeister, Hutter, & Bengel, 2011), SSRIs produced a small but clinically 
significant reduction in depressive symptoms when compared to placebo. Still, 
approximately 15% to 25% of patients fail to continue antidepressant medication 
treatment because of adverse side effects or perceived lack of efficacy (Lichtman et al., 
2008); yet others benefit from combined interventions involving pharmacotherapy, 
psychotherapy, or other therapies (Kronish et al., 2012). Thus, there has been great 
interest in the evaluation and development of psychosocial interventions for MDD in 
CHD patients.  
Relevant to CHD patients enrolled in CR, there is mounting evidence in support 
of physical activity as an effective nonpharmacological intervention for depression that 
also positively impacts a wide array of risk factors linking depression and CHD (Lett et 
al., 2004). Results from psychological and exercise intervention studies demonstrate that 
exercise significantly improves mood (e.g., depression severity) and physiological (e.g., 
peak VO2 consumption, exercise duration on a treadmill stress test) outcomes; these 
effects are better than medications or treatment as usual (Blumenthal et al., 2007; 
Blumenthal et al., 2012). In order to maximize clinical health outcomes, patients with 
CHD and depression may benefit most from interventions that simultaneously target both 
depression and cardiovascular risk factors (Lett et al., 2005). More specifically, depressed 
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patients with CHD may benefit from evidence-based treatments such as cognitive-
behavioral therapy (CBT) for depression (Beck et al., 1979; Beck, 1995) or stress 
management training (Blumenthal et al., 2005; Freedland et al., 2009). These treatments 
emphasize psychoeducation about heart disease, risk factors, and emotional stress; skills 
training (e.g., progressive muscle relaxation, imagery, cognitive restructuring, problem 
solving, time management) to manage somatic symptoms and stress; and social support. 
Although CR typically incorporates multidisciplinary education and stress management, 
programs remain heterogeneous in structure. Systematic dissemination and 
implementation of evidence-based treatments for depression within inpatient settings 
(i.e., during hospitalization for the incident coronary event) and outpatient CR programs 
may serve to improve mental health and cardiovascular outcomes, thereby alleviating an 
enormous public health burden. 
In a review of 64 randomized controlled trials of psychological interventions 
among CHD patients, characteristics of interventions associated with improvement in 
depressive symptoms were identified in attempt to isolate the effects of psychological 
components of treatment (Dickens et al., 2013). Among 12 studies that presented data on 
depressed coronary patients, the overall effect size for psychological interventions was 
small but significant (d = .18). Significant effects were seen for general education (d = 
.52), behavioral therapy (d = .44), CBT (d = .29), and relaxation (d = .30); however, only 
CBT showed a significant effect (d = .31) within the subset of 7 studies that met 
standards for high methodological quality.  
Although CBT for depression and stress management training are effective in the 
reduction of depressive symptoms in cardiac patients, there is currently no direct 
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evidence to demonstrate that psychological treatment improves cardiac outcomes or 
mortality. The Enhancing Recovery in Coronary Heart Disease (ENRICHD) study was 
the largest and only randomized controlled trial powered to test the efficacy of depression 
treatment in cardiac patients post-MI (Berkman et al., 2003). The ENRICHD study 
design included a psychosocial intervention (CBT), singly and in combination with 
sertraline. Compared to usual care, the enhanced CBT intervention yielded significant but 
modest improvements (d = 0.31) in depression, as evidenced by a 49% vs. 33% mean 
decrease on the BDI, and a comparable difference observed on the structured interview 
assessment of depressive symptom severity. There were no significant differences in all-
cause mortality or MI recurrence between the enhanced psychological intervention and 
usual care conditions (Carney et al., 2004). Therefore, until there is evidence that 
treatment of depression improves outcomes or survival, it remains unproven whether 
depression is a causal risk factor for CHD.  
Limitations 
Study limitations should be taken into account when interpreting results and 
drawing conclusions. First, there were some important limitations related to the 
composition of the current sample. As discussed in the clinical implications section 
above, the vast majority of the sample (91.4%) reported minimal symptoms of depression 
at baseline. Thus, results of the current study may not be broadly generalizable, as 
previous studies show much higher rates of depression in patients with MI and coronary 
artery disease (Lett et al., 2004; Rutledge et al., 2006; van Melle et al., 2004). Moreover, 
although this study was conducted in a community sample, demographic homogeneity 
limits generalizability. Replication of results is needed to verify specific findings and to 
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better understand the unique determinants of cardiovascular health in ethnic minority, 
female, and socioeconomically disadvantaged patients with CHD. As mentioned earlier, 
these minority populations are in greater need of health promotion and secondary 
prevention efforts, as they show lower rates of enrollment in CR and higher rates of 
medical comorbidities and physical disability.  
A second limitation of this project relates to the operational definition of 
treatment adherence. Although CR is a comprehensive multidisciplinary program, for the 
purposes of the current project, CR attendance and completion referred to engagement in 
the exercise portion of the program and did not include adherence to or completion of 
other multimodal interventions that are integral to CR. Baseline depression very likely 
influenced participation in stress management, nutrition, smoking cessation, and medical 
education sessions. Participation in these interventions likely also impacted exercise 
adherence and completion as well as cardiorespiratory fitness outcomes. Another related 
limitation pertains to the definition of CR completion status. Treatment completion status 
was broadly defined by collapsing cases in which there was a clear external factor that 
contributed lower attendance in CR. However, the definition of CR completion is not 
well defined in the literature; more research is needed to determine how best to account 
for early termination, insurance coverage, and other factors unique to CR. Although this 
definition accounted for major external factors that affected attendance rates, it is 
possible that methodological issues remained in the operationalization of CR completion 
status. For example, combining patients who terminated CR early for differing reasons 
(i.e., insurance limitations, good clinical progress) may have failed to distinguish 
important subgroup differences, such as motivation or willingness to engage in exercise.  
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Third, important covariates (e.g., BMI, cholesterol levels, physiological markers 
of heart disease severity, mental health history, motivation to change lifestyle or risk 
factors) that impact treatment adherence and cardiorespiratory fitness were not available 
for the current project and therefore, could not be accounted for in MIMIC models. 
Previous research indicates that patients with a prior history of depression face higher 
risk for secondary cardiovascular events and poorer adherence in CR than patients who 
experience depression secondary to a coronary event (Ades et al., 1992a). In the current 
study, without mental health history information, it was not possible to delineate whether 
baseline depression preceded the incident coronary event. Additionally, no data were 
collected to assess attendance in stress management sessions or formal mental health 
treatment; patients with elevated depressive symptoms who were engaged in these 
concurrent treatments may have uniquely benefited with respect to cardiorespiratory 
fitness outcomes, treatment adherence, and CR completion.  
Fourth, although the PHQ-9 has been demonstrated to be a valid and reliable 
measure of depression, it should be noted that the measure includes items that tap into 
somatic symptoms that may be conflated with comorbid medical symptoms in patients 
with coronary heart disease. Other measures, such as the Hospital Anxiety and 
Depression Scale (HADS; Zigmond & Snaith, 1983), have been normed in hospital 
patients and do not include certain items (e.g., fatigue, sleep, appetite/weight), and may 
be a good alternative measure of depression. 
Study Conclusions and Future Directions 
The current study contributes uniquely to the growing field of behavioral 
cardiology by examining the relations between baseline depression and cardiorespiratory 
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fitness in a large community sample of predominantly non-depressed patients enrolled in 
CR. This study provides further evidence to support the impact of clinical levels of 
depression on treatment adherence in a secondary prevention setting and contributes to a 
growing body of research that indicates depression is an independent risk factor for CHD 
and adverse cardiac events.  
As suggested above, replication of results in a more ecologically valid sample will 
lend credibility to the novel findings presented in this paper. Replication will be 
particularly important to confirm that higher depression scores predict a lower likelihood 
of CR completion, as this major finding has the greatest clinical implications for 
treatment and prevention efforts. Although this study did not lend support for CR 
attendance or completion status mediating the relation between depression and 
cardiorespiratory fitness, future studies examining mechanisms of depression in CHD 
may extend current research by further testing the latent construct of cardiorespiratory 
fitness and considering the role of important covariates (e.g., BMI, cholesterol levels, 
disease severity index, mental health history, motivation to change behavioral risk 
factors). The adherence constructs, CR attendance and CR completion, should be further 
studied and may be refined through the development of a reliable metric to define 
treatment adherence to rehabilitation protocols. One possibility is to develop an 
underlying latent construct for CR adherence, with rates of attendance (percentage of 
total possible sessions attended) across individual components of intervention (e.g., 
exercise, stress management, nutrition, smoking cessation) representing individual 
indicators. Future studies would also benefit from integrating biological mechanisms 
such as heart rate variability, hormone levels, and inflammatory biomarkers and testing 
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the interactions between biological and behavioral mechanisms of depression in CHD. 
The ultimate goal of this line of work would be to improve early detection of depression 
in the context of CHD and to recommend specific treatments that are tailored to specific 
predisposing risk factors in the prevention of secondary cardiovascular events.  
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